Atorvastatin 20 mg film-coated tablets

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

即購入

製品の特徴 製品の特徴 (SPC)
27-09-2019

有効成分:

Atorvastatin-calcium

から入手可能:

Actavis Group PTC ehf

ATCコード:

C10AA; C10AA05

INN(国際名):

Atorvastatin-calcium

投薬量:

20 milligram(s)

医薬品形態:

Film-coated tablet

処方タイプ:

Product subject to prescription which may be renewed (B)

治療領域:

HMG CoA reductase inhibitors; atorvastatin

認証ステータス:

Marketed

承認日:

2009-09-18

情報リーフレット

                                ATORVASTATIN 10 MG, 20 MG, 40 MG & 80 MG
FILM-COATED TABLETS
Atorvastatin
PACKAGE LEAFLET: INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to
read it again.
•
If you have any further questions,
ask your doctor or pharmacist.
•
This medicine has been prescribed
for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as
yours.
•
If you get any side effects, talk to
your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET
1
WHAT ATORVASTATIN IS AND WHAT
IT IS USED FOR
2
WHAT YOU NEED TO KNOW
BEFORE YOU TAKE ATORVASTATIN
3
HOW TO TAKE ATORVASTATIN
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE ATORVASTATIN
6
CONTENTS OF THE PACK AND
OTHER INFORMATION
1
WHAT ATORVASTATIN IS AND WHAT
IT IS USED FOR
Atorvastatin belongs to a group of
medicines known as statins, which are
lipid (fat) regulating medicines.
Atorvastatin is used to lower lipids
known as cholesterol and triglycerides
in the blood when a low fat diet and
life style changes on their own have
failed. If you are at an increased risk
of heart disease, Atorvastatin can also
be used to reduce such risk even if
your cholesterol levels are normal. You
should maintain a standard cholesterol
lowering diet during treatment.
2
WHAT YOU NEED TO KNOW
BEFORE YOU TAKE ATORVASTATIN
DO NOT TAKE ATORVASTATIN:
•
if you are allergic to Atorvastatin
or any of the other ingredients of
medicine (listed in section 6)
•
if you have or have ever had a disease
which affects the liver
•
if you have had any unexplained
abnormal blood tests for liver function
•
if you are a woman able to have
children and not using reliable
contraception
•
if you are pregnant or trying to
become pregnant
•
if you are breast-feeding
•
if you use the combination of
glecaprevir/pibrentasvir in the
treatment of hepatitis C.
WARNINGS AND PRE
                                
                                完全なドキュメントを読む
                                
                            

製品の特徴

                                HealthProductsRegulatoryAuthority
26September2019
CRN0091QN
Page1of18
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Atorvastatin20mgfilm-coatedtablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Eachfilm-coatedtabletcontains20
mgofatorvastatinasatorvastatincalciumtrihydrate.
For thefulllistofexcipients,seesection6.1.
3 PHARMACEUTICAL FORM
Film-coatedtablet.
White,oval,biconvex6.2x11.5mm
film-coatedtabletsmarkedwith“20”ononesideand“A”ontheother.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Hypercholesterolaemia
Atorvastatinisindicatedasanadjuncttodietforreductionofelevatedtotalcholesterol(total-C),LDL-cholesterol(LDL-C),
apolipoproteinB,andtriglyceridesinadults,adolescentsandchildrenaged10yearsorolderwithprimary
hypercholesterolaemiaincludingfamilialhypercholesterolaemia(heterozygousvariant)orcombined(mixed)hyperlipidaemia
(correspondingtoTypesIIaandIIboftheFredricksonclassification)whenresponsetodietandothernonpharmacological
measuresisinadequate.
Atorvastatinisalsoindicatedtoreducetotal-CandLDL-Cinadultswithhomozygousfamilialhypercholesterolaemiaasan
adjuncttootherlipid-loweringtreatments(e.g.LDLapheresis)orifsuchtreatmentsareunavailable.
Prevention of cardiovascular disease
Preventionofcardiovasculareventsinadultpatientsestimatedtohaveahighriskforafirstcardiovascularevent(seesection
5.1),asanadjuncttocorrectionofotherriskfactors.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Thepatientshouldbeplacedonastandardcholesterol-loweringdietbeforer
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索